Bulwa Zachary B, Mendelson Scott J, Brorson James R
Department of Neurology, Rush University Medical Center, Chicago, IL, United States.
Department of Neurology, The University of Chicago, Chicago, IL, United States.
Front Neurol. 2021 Sep 10;12:701168. doi: 10.3389/fneur.2021.701168. eCollection 2021.
Recent studies of interventions initiated acutely following onset of minor ischemic stroke or transient ischemic attack (TIA) have disclosed early stroke recurrence rates that are substantially higher than long-term recurrence rates and that can be reduced by acute antiplatelet treatment interventions. These observations, bolstered by analysis based on kinetic modeling of the time course of recurrence following initial events, suggest that acute stroke patients experience an underlying vulnerable state that quickly transitions to a more stable state. Some evidence also supports the benefits of early treatment with direct-acting oral anticoagulants in cardioembolic stroke and of continuation or early initiation of statin therapy in atherosclerotic stroke. Treatment of ischemic stroke should address the transient vulnerable state that follows the initial event, employing measures aiming to avert early recurrence of thromboembolism and to promote stabilization of vulnerable arterial plaque. These measures constitute following ischemic stroke.
近期针对轻度缺血性卒中或短暂性脑缺血发作(TIA)发作后立即启动的干预措施的研究表明,早期卒中复发率远高于长期复发率,且急性抗血小板治疗干预措施可降低该复发率。基于初始事件后复发时间进程的动力学模型分析进一步证实了这些观察结果,表明急性卒中患者经历了一个潜在的易损状态,该状态会迅速转变为更稳定的状态。一些证据还支持在心源性栓塞性卒中中早期使用直接口服抗凝剂治疗以及在动脉粥样硬化性卒中中继续或早期启动他汀类药物治疗的益处。缺血性卒中的治疗应针对初始事件后的短暂易损状态,采取措施以避免血栓栓塞的早期复发并促进易损动脉斑块的稳定。这些措施构成了缺血性卒中后的治疗。